Annual SGA
$24.95 M
-$9.44 M-27.44%
December 31, 2023
Summary
- As of February 8, 2025, VVOS annual SGA is $24.95 million, with the most recent change of -$9.44 million (-27.44%) on December 31, 2023.
- During the last 3 years, VVOS annual SGA has risen by +$6.54 million (+35.55%).
- VVOS annual SGA is now -27.44% below its all-time high of $34.38 million, reached on December 31, 2022.
Performance
VVOS SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$4.83 M
+$391.00 K+8.80%
September 30, 2024
Summary
- As of February 8, 2025, VVOS quarterly SGA is $4.83 million, with the most recent change of +$391.00 thousand (+8.80%) on September 30, 2024.
- Over the past year, VVOS quarterly SGA has dropped by -$1.24 million (-20.42%).
- VVOS quarterly SGA is now -48.80% below its all-time high of $9.44 million, reached on December 31, 2021.
Performance
VVOS Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$389.97 M
-$12.57 M-3.33%
September 30, 2024
Summary
- As of February 8, 2025, VVOS TTM SGA is -$389.97 million, with the most recent change of -$12.57 million (-3.33%) on September 30, 2024.
- Over the past year, VVOS TTM SGA has dropped by -$414.91 million (-1663.38%).
- VVOS TTM SGA is now -1575.28% below its all-time high of -$23.28 million.
Performance
VVOS TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
VVOS Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -27.4% | -20.4% | -1663.4% |
| 3 y3 years | +35.5% | -43.1% | -1526.9% |
| 5 y5 years | +139.0% | -18.4% | -2096.8% |
VVOS Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -27.4% | at low | -48.8% | +8.8% | -110.4% | at low |
| 5 y | 5-year | -27.4% | +35.5% | -48.8% | +21.9% | -1575.3% | at low |
| alltime | all time | -27.4% | +139.0% | -48.8% | +21.9% | -1575.3% | at low |
Vivos Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $4.83 M(+8.8%) | $20.92 M(-1.9%) |
| Jun 2024 | - | $4.44 M(-20.3%) | $21.33 M(-8.7%) |
| Mar 2024 | - | $5.58 M(-8.2%) | $23.35 M(-6.4%) |
| Dec 2023 | $24.95 M(-27.4%) | $6.07 M(+16.0%) | $24.94 M(-8.1%) |
| Sep 2023 | - | $5.24 M(-19.0%) | $27.15 M(-8.4%) |
| Jun 2023 | - | $6.47 M(-9.8%) | $29.64 M(-9.0%) |
| Mar 2023 | - | $7.17 M(-13.4%) | $32.56 M(-5.4%) |
| Dec 2022 | $34.38 M(+9.7%) | $8.28 M(+7.1%) | $34.42 M(-3.3%) |
| Sep 2022 | - | $7.73 M(-17.7%) | $35.59 M(-2.1%) |
| Jun 2022 | - | $9.39 M(+4.0%) | $36.35 M(+5.5%) |
| Mar 2022 | - | $9.03 M(-4.4%) | $34.45 M(+9.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $31.34 M(+70.3%) | $9.44 M(+11.1%) | $31.34 M(+14.7%) |
| Sep 2021 | - | $8.49 M(+13.4%) | $27.33 M(+18.5%) |
| Jun 2021 | - | $7.49 M(+26.5%) | $23.06 M(+18.1%) |
| Mar 2021 | - | $5.92 M(+9.1%) | $19.53 M(+6.1%) |
| Dec 2020 | $18.40 M(-0.4%) | $5.43 M(+28.6%) | $18.40 M(+5.1%) |
| Sep 2020 | - | $4.22 M(+6.5%) | $17.51 M(-6.5%) |
| Jun 2020 | - | $3.96 M(-17.3%) | $18.72 M(+26.8%) |
| Mar 2020 | - | $4.79 M(+5.6%) | $14.76 M(+48.1%) |
| Dec 2019 | $18.48 M(+77.1%) | $4.54 M(-16.4%) | $9.97 M(+83.6%) |
| Sep 2019 | - | $5.43 M | $5.43 M |
| Dec 2018 | $10.44 M | - | - |
FAQ
- What is Vivos Therapeutics annual SGA?
- What is the all time high annual SGA for Vivos Therapeutics?
- What is Vivos Therapeutics annual SGA year-on-year change?
- What is Vivos Therapeutics quarterly SGA?
- What is the all time high quarterly SGA for Vivos Therapeutics?
- What is Vivos Therapeutics quarterly SGA year-on-year change?
- What is Vivos Therapeutics TTM SGA?
- What is the all time high TTM SGA for Vivos Therapeutics?
- What is Vivos Therapeutics TTM SGA year-on-year change?
What is Vivos Therapeutics annual SGA?
The current annual SGA of VVOS is $24.95 M
What is the all time high annual SGA for Vivos Therapeutics?
Vivos Therapeutics all-time high annual SGA is $34.38 M
What is Vivos Therapeutics annual SGA year-on-year change?
Over the past year, VVOS annual SGA has changed by -$9.44 M (-27.44%)
What is Vivos Therapeutics quarterly SGA?
The current quarterly SGA of VVOS is $4.83 M
What is the all time high quarterly SGA for Vivos Therapeutics?
Vivos Therapeutics all-time high quarterly SGA is $9.44 M
What is Vivos Therapeutics quarterly SGA year-on-year change?
Over the past year, VVOS quarterly SGA has changed by -$1.24 M (-20.42%)
What is Vivos Therapeutics TTM SGA?
The current TTM SGA of VVOS is -$389.97 M
What is the all time high TTM SGA for Vivos Therapeutics?
Vivos Therapeutics all-time high TTM SGA is -$23.28 M
What is Vivos Therapeutics TTM SGA year-on-year change?
Over the past year, VVOS TTM SGA has changed by -$414.91 M (-1663.38%)